GlaxoSmithKline's Hib vaccine obtains FDA approval

08/20/2009 | Philadelphia Inquirer, The

GlaxoSmithKline gained accelerated FDA clearance for Hiberix, a vaccine against Haemophilus influenzae Type B, which causes diseases such as meningitis and pneumonia. The approval allows the drug to be used as a booster in children 15 months to 4 years old and is part of an effort to address a shortage of Merck & Co.'s PedvaxHIB.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations